AbbVie Commits $100B in US R&D, Manufacturing, Winning Tariff, Pricing Exemptions

AbbVie has also pledged to participate in TrumpRx and offer many of its products, including Humira, on a direct-to-patient basis. In exchange, the pharma secured exemptions from tariffs and other future pricing directives.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top